Platelet hyperaggregability as a consequence of the nephrotic syndrome.
D000293:Adolescent; D000328:Adult; D001241:Aspirin / Q000627:therapeutic use; D001791:Blood Platelet Disorders / Q000209:etiology*; D003404:Creatinine / Q000652:urine; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000150:complications*; D010973:Platelet Adhesiveness / Q000187:drug effects; D010974:Platelet Aggregation / Q000187:drug effects; D010978:Platelet Factor 4; D010979:Platelet Function Tests; D013923:Thromboembolism / Q000209:etiology; D001620:beta-Thromboglobulin / Q000652:urine
D001620:beta-Thromboglobulin; D010978:Platelet Factor 4; D003404:Creatinine; D001241:Aspirin